No.7
適時開示 適時開示
2026/09/29 17:52
海外規制公告
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
📄 開示資料(HKEXnews)を開く
削除
No.6
適時開示 適時開示
2026/09/29 17:51
海外規制公告(その他)
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
📄 開示資料(HKEXnews)を開く
削除
No.5
適時開示 適時開示
2026/09/22 18:27
海外規制公告(その他)
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
📄 開示資料(HKEXnews)を開く
削除
No.4
適時開示 適時開示
2026/09/22 17:41
中間報告書
2026 Interim Report
📄 開示資料(HKEXnews)を開く
削除
No.3
適時開示 適時開示
2026/09/18 17:59
海外規制公告(その他)
Overseas Regulatory Announcement-Announcement on Levocarnitine Oral Solution having obtained Drug Registration Certificate
📄 開示資料(HKEXnews)を開く
削除
No.2
適時開示 適時開示
2026/09/18 17:59
海外規制公告(その他)
Overseas Regulatory Announcement-Announcement on Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution Having Obtained Drug Registration Certificate
📄 開示資料(HKEXnews)を開く
削除
No.1
適時開示 適時開示
2026/09/18 17:58
海外規制公告(その他)
Overseas Regulatory Announcement-Announcement on Donepezil Hydrochloride Orally Disintegrating Tablets of Subsidiary Having Obtained Drug Registration Certificate
📄 開示資料(HKEXnews)を開く
削除